A detailed history of Peoples Bank/Ks transactions in Novartis Ag stock. As of the latest transaction made, Peoples Bank/Ks holds 6,538 shares of NVS stock, worth $634,709. This represents 0.5% of its overall portfolio holdings.

Number of Shares
6,538
Previous 6,573 0.53%
Holding current value
$634,709
Previous $700 Million 7.47%
% of portfolio
0.5%
Previous 0.55%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$106.13 - $120.89 $3,714 - $4,231
-35 Reduced 0.53%
6,538 $752 Million
Q2 2024

Jul 15, 2024

SELL
$92.57 - $107.37 $10,182 - $11,810
-110 Reduced 1.65%
6,573 $700 Million
Q1 2024

Apr 03, 2024

SELL
$95.27 - $108.47 $27,628 - $31,456
-290 Reduced 4.16%
6,683 $646 Million
Q4 2023

Jan 04, 2024

SELL
$92.27 - $101.54 $25,558 - $28,126
-277 Reduced 3.82%
6,973 $704 Million
Q3 2023

Oct 30, 2023

BUY
$94.73 - $105.13 $686,792 - $762,192
7,250 New
7,250 $738 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Peoples Bank/Ks Portfolio

Follow Peoples Bank/Ks and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank/Ks, based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank/Ks with notifications on news.